Study in Adult Subjects Undergoing Posterolateral Thoracotomy
Status:
Terminated
Trial end date:
2018-09-28
Target enrollment:
Participant gender:
Summary
Primary Objective: To characterize the pharmacokinetic (PK) profile of EXPAREL when
administered as a posterior intercostal nerve block.
Secondary Objective: To assess the safety and tolerability of EXPAREL in this surgical model.